VivaTech 2025


Our Latest Stories

Our Science

June 10, 2025

Advancing Patient- and Provider-Centric Care in Multiple Myeloma

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

86

Compounds in clinical development

24

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


June 9, 2025
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

June 7, 2025
Media Update: RAD: Dupixent data reinforce use in atopic dermatitis patients with skin of color

June 6, 2025
Media Update: ISTH: new data highlight innovation from Sanofi’s pipeline in rare diseases

June 5, 2025
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan